MHRA approves lurbinectedin for adults with extensive-stage small cell lung cancer
RegulatoryapprovedlurbinectedinPositive
AI Analysis
Summary
The MHRA has approved lurbinectedin for treating adults with extensive-stage small cell lung cancer. The regulatory agency will continue to monitor the drug's safety and effectiveness post-approval.
Outcome Details
MHRA approval for lurbinectedin in adults with extensive-stage small cell lung cancer
Importance:8/10
Sentiment:
0.80
MHRA approvallurbinectedinsmall cell lung cancerregulatory
Read the original article
Published by MHRA (UK) on September 23, 2026 4:09 PM